FIELD: medicine, vaccines. SUBSTANCE: invention relates to a method of live measles vaccine producing. Method involves the use of cultural virus-containing liquid (specific activity is 3.3 lg NCD50/0.5 ml, not less) as a liquid form. Live measles vaccine is mixed with gelatin and sorbitol as a stabilizing agent at ratio 1:1 at amount 10% of the live measles vaccine semifinished product, not less. For preparing the liposomal form virus-containing liquid and stabilizing agent are mixed with phosphatidylcholine and cholesterol at the definite ratio of components. Obtained vaccine is administrated in organism by oral route at the single dose 20 000 NCD50 of measles virus, not less. Immunogenicity of vaccine is comparable with that of commercial injection form of the live measles vaccine but does not induce adverse reactions. EFFECT: improved method of preparing. 2 cl, 1 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF LIVE ANTIMEASLES VACCINE PREPARING | 1998 |
|
RU2140288C1 |
METHOD FOR OBTAINING MICROCAPSULATED FORM OF MEASLES VACCINE FOR PERORAL INTAKE | 2001 |
|
RU2210361C2 |
METHOD OF LIVE ANTIMEASLES VACCINE PREPARING | 1996 |
|
RU2123331C1 |
METHOD OF LIVE ANTIMEASLES VACCINE PREPARING | 1995 |
|
RU2112545C1 |
LIPOSOMAL ANTIVIRAL DRUG FOR ORAL USING | 1996 |
|
RU2123328C1 |
LIVE VACCINE FOR MEASLES PROPHYLAXIS | 1996 |
|
RU2129876C1 |
METHOD OF OBTAINING MICROENCAPSULATED FORMS OF LIVE CULTURE VACCINE AGAINST SEASONAL AND PANDEMIC INFLUENZA FOR INTRANASAL USE | 2016 |
|
RU2617051C1 |
TABLETED LIVE RECOMBINANT BIVACCINE "REVAKS VKT" AGAINST NATURAL SMALLPOX AND HEPATITIS B AND METHOD FOR ITS PREPARING | 2002 |
|
RU2242246C2 |
LIVE CULTURAL ANTIMEASLES VACCINE | 1998 |
|
RU2144369C1 |
VACCINE AGAINST AVIAN INFECTIOUS BURSITIS | 1998 |
|
RU2127604C1 |
Authors
Dates
1999-07-27—Published
1997-07-16—Filed